Human Health and Product Characterization Risk Assessment for three PIP Active Ingredients: SpCas9 and gRNAs for LoF Edits to ACD2, LLS1, PLCP

The eRulemaking Program published this content on December 22, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 22, 2025 at 19:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]